| Literature DB >> 26833722 |
Naghmeh Naderi1,2, Emman J Combellack1,2, Michelle Griffin3, Tina Sedaghati3, Muhammad Javed1,2, Michael W Findlay4, Christopher G Wallace5, Afshin Mosahebi3,6, Peter Em Butler6, Alexander M Seifalian3, Iain S Whitaker1,2.
Abstract
The potential use of stem cell-based therapies for the repair and regeneration of various tissues and organs offers a paradigm shift in plastic and reconstructive surgery. The use of either embryonic stem cells (ESC) or induced pluripotent stem cells (iPSC) in clinical situations is limited because of regulations and ethical considerations even though these cells are theoretically highly beneficial. Adult mesenchymal stem cells appear to be an ideal stem cell population for practical regenerative medicine. Among these cells, adipose-derived stem cells (ADSC) have the potential to differentiate the mesenchymal, ectodermal and endodermal lineages and are easy to harvest. Additionally, adipose tissue yields a high number of ADSC per volume of tissue. Based on this background knowledge, the purpose of this review is to summarise and describe the proliferation and differentiation capacities of ADSC together with current preclinical data regarding the use of ADSC as regenerative tools in plastic and reconstructive surgery.Keywords: ADSC; Reconstructive surgery; Stem cells; Tissue engineering
Mesh:
Year: 2016 PMID: 26833722 PMCID: PMC7949873 DOI: 10.1111/iwj.12569
Source DB: PubMed Journal: Int Wound J ISSN: 1742-4801 Impact factor: 3.315